Cardiomyocyte ryanodine receptor degradation by chaperone-mediated autophagy

Cardiovascular Research

Volumn 98, Issue 2, 2013, Pages 277-285

  Pedrozo, Zully ^a,b   Torrealba, Natalia ^a   Fernández, Carolina ^a   Gatica, Damian ^a   Toro, Barbra ^a   Quiroga, Clara ^a   Rodriguez, Andrea E ^a   Sanchez, Gina ^a,b   Gillette, Thomas G ^c   Hill, Joseph A ^c   Donoso, Paulina ^a,b   Lavandero, Sergio ^a,b,c  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cardiomyocyte; Chaperone mediated autophagy; Geldanamycin; Protein degradation; Ryanodine receptor

Indexed keywords

CARDIOMYOCYTE RYANODINE RECEPTOR; DIHYDRORHODAMINE 123; GELDANAMYCIN; HEAT SHOCK COGNATE PROTEIN 70; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; RYANODINE RECEPTOR; RYANODINE RECEPTOR 2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; AUTOPHAGOSOME; CELL NUCLEUS; CELL VIABILITY; CHAPERONE-MEDIATED AUTOPHAGY; HEART EXCITATION; HEART MUSCLE CELL; LYSOSOME MEMBRANE; MACROAUTOPHAGY; MOLECULAR RECOGNITION; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; RAT;

AMINO ACID SEQUENCE; ANIMALS; AUTOPHAGY; BENZOQUINONES; LACTAMS, MACROCYCLIC; LYSOSOMES; MOLECULAR CHAPERONES; MOLECULAR SEQUENCE DATA; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PRESENILINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 84877268947     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt029     Document Type: Article

References (34)

1. Bers DM. Cardiac excitation-contraction coupling. Nature 2001;415:198-205.
2. Walsh LG, Tormey JMCD. Subcellular electrolyte shifts during in vitro myocardial ischemia and reperfusion. Am J Physiol 1998;255:H917-H928.
3. Chohan PK, Singh RB, Dhalla NS, Netticadan T. L-arginine administration recovers sarcoplasmic reticulum function in ischemic reperfused hearts by preventing calpain activation. Cardiovasc Res 2006;69:152-163.
4. Singh RB, Chohan PK, Dhalla NS, Netticadan T. The sarcoplasmic reticulum proteins are targets for calpain action in the ischemic-reperfused heart. J Mol Cell Cardiol 2004; 37:101-110.
5. Takeda S, Mochizuki S, Saini HK, Elimban V, Dhalla NS. Modification of alterations in cardiac function and sarcoplasmic reticulum by vanadate in ischemic-reperfused rat hearts. J Appl Physiol 2005;99:999-1005.
6. Temsah RM, Netticadan T, Chapman D, Takeda S, Mochizuki S, Dhalla NS. Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am J Physiol 1999;277:H584-H594.
7. Domenech RJ, Sanchez G, Donoso P, Parra V, Macho P. Effect of tachycardia on myocardial sarcoplasmic reticulum and Ca2+ dynamics: a mechanism for preconditioning J Mol Cell Cardiol 2003;35:1429-1437.
8. Guo Z, Wang S, Jiao Q, Xu M, Gao F. RNAi targeting ryanodine receptor 2 protects rat cardiomyocytes from injury caused by simulated ischemia- reperfusion. Biomed Pharmacoter 2010;64:184-190.
9. Fauconnier J, Meli AC, Thireau J, Roberge S, Shan J, Sassi Y et al. Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusion. Proc Natl Acad Sci USA 2011;108:13258-13263.
10. Pedrozo Z, Sanchez G, Torrealba N, Valenzuela R, Fernandez C, Hidalgo C et al. Calpains and proteasomes mediate degradation of ryanodine receptors in a model of cardiac ischemic reperfusion. Biochim Biophys Acta 2010;1802:356-362.
11. Kaushik S, Massey AC, Mizushima N, Cuervo AM. Constitutive activation of chaperone-mediated autophagy in cells with impaired macroautophagy. Mol Biol Cell 2008;19:2179-2192.
12. Kiffin R, Christian C, Knecht E, Cuervo AM. Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell 2004;15:4829-4840.
13. Kaushik S, Cuervo AM. Autophagy as a cell-repair mechanisms: activation of chaperone-mediated autophagy during oxidative stress. Mol Aspects Med 2006;27: 444-454.
14. Finn PF, Mesires NT, Vine M, Dice JF. Effects of small molecules on chaperonemediated autophagy. Autophagy 2005;1:141-145.
15. Foncea R, Andersson M, Ketterman A, Blakesley V, Sapag-Hagar M, Sugden PH et al. Insulin-like growth factor-I rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes. J Biol Chem 1997;272:19115-19124.
16. Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L. Wild type a-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 2008;283:23542-23556.
17. Hartree EF. Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem 1972;48:422-427.
18. Kon M, Cuervo AM. Chaperone-mediated autophagy in health and disease. FEBS Lett 2010;584:1399-1404.
19. Kaushik S, Cuervo AM. Methods to monitor chaperone-mediated autophagy. Methods Enzymol 2009;452:297-324.
20. Li W, Yang Q, Mao Z. Chaperone-mediated autophagy: machinery, regulation and biological consequences. Cell Mol Life Sci 2011;68:749-763.
21. Kiffin R, Bandyopadhyay U, Cuervo AM. Oxidative stress and autophagy. Antioxid Redox Signal 2006;8:152-162.
22. Liu H, Wang P, Song W, Sun X. Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways. FASEB J 2009;23:3383-3392.
23. Dikalov S, Landmesser U, Harrison DG. Geldanamycin leads to superoxide formation by enzymatic and non-enzymatic redox cycling. Implications for studies of Hsp90 and endothelial cell nitric-oxide synthase. J Biol Chem 2002;277:25480-25485.
24. Cysyk RL, Parker RJ, Barchi Jr JJ, Steeg PS, Hartman NR, Strong JM. Reaction of geldanamycin and C17-substituted analogues with glutathione: product identifications and pharmacological implications. Chem Res Toxicol 2006;19:376-381.
25. Rajgopal Y, Vemuri MC. Calpain activation and alpha-spectrin cleavage in rat rain by ethanol. Neurosci Lett 2002;321:187-191.
26. Dice JF. Chaperone-mediated autophagy. Autophagy 2007;3:295-299.
27. Shen S, Zhang P, Lovchik MA, Li Y, Tang L, Chen Z et al. Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy. J Cell Biol 2009;185:629-639.
28. Sreedhar AS, Mihaly K, Pato B, Schnaider T, Stetak A, Kis-Petik K et al. Hsp90 inhibition accelerates cell lysis. Anti-Hsp90 ribozyme reveals a complex mechanism of Hsp90 inhibitors involving both superoxide-and Hsp90-dependent events. J Biol Chem 2003;278:35231-35240.
29. Zhang H, Burrows F. Targeting multiple signal transduction pathways through inhibition of Hsp90. J Mol Med 2004;82:488-499.
30. Donoso P, Sanchez G, Bull R, Hidalgo C. Modulation of cardiac ryanodine receptor activity by ROS and RNS. Front Biosci 2011;16:553-567.
31. Marengo JJ, Hidalgo C, Bull R. Sulfhydryl oxidation modifies the calcium dependence of ryanodine-sensitive calcium channels of excitable cells. Biophys J 1998;74: 1263-1277.
32. Beel AJ, Sanders CR. Substrate specificity of g-secretase and other intramembrane proteases. Cell Mol Life Sci 2008;65:1311-1334.
33. Takeda T, Asahi M, Yamaguchi O, Hikoso S, Nakayama H, Kusakari Y et al. Presenilin 2 regulates the systolic function of heart by modulating Ca2+ signalling. FASEB J 2005;19: 2069-2071.
34. Peng X, Pentassuglia L, Sawyer DB. Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern Circ Res 2010;106:1022-1034.